Savanna Biotherapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 4

Savanna Biotherapeutics General Information

Description

The company is currently operating in Stealth mode.

Contact Information

Formerly Known As
Novoglia
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/o University Lab Partners, Curie Hall
  • 1 University Drive
  • Aliso Viejo, CA 92656
  • United States
+1 (716)
Primary Industry
Other Commercial Products
Other Industries
Other Commercial Services
Other Consumer Durables
Other Services (B2C Non-Financial)
Corporate Office
  • C/o University Lab Partners, Curie Hall
  • 1 University Drive
  • Aliso Viejo, CA 92656
  • United States
+1 (716)

Savanna Biotherapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Savanna Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 08-Aug-2025 Completed Stealth
3. Later Stage VC (Series A3) 28-Jun-2025 Completed Stealth
2. Early Stage VC (Series A) 17-Nov-2022 $24.3M $24.3M Completed Stealth
1. Grant 01-Jan-2021 $399K Completed Stealth
To view Savanna Biotherapeutics’s complete valuation and funding history, request access »

Savanna Biotherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3
Series A-2
Series A-1 3,005,292 $0.000100 $1.43 $1.43 1x $1.43 6.38%
To view Savanna Biotherapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Savanna Biotherapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Civilization Ventures Venture Capital Minority
Iaso Ventures Venture Capital Minority
Medical Excellence Capital Venture Capital Minority
National Institutes of Neurological Disorders and Stroke Government
To view Savanna Biotherapeutics’s complete investors history, request access »

Savanna Biotherapeutics FAQs

  • When was Savanna Biotherapeutics founded?

    Savanna Biotherapeutics was founded in 2020.

  • Where is Savanna Biotherapeutics headquartered?

    Savanna Biotherapeutics is headquartered in Aliso Viejo, CA.

  • What industry is Savanna Biotherapeutics in?

    Savanna Biotherapeutics’s primary industry is Other Commercial Products.

  • Is Savanna Biotherapeutics a private or public company?

    Savanna Biotherapeutics is a Private company.

  • What is Savanna Biotherapeutics’s current revenue?

    The current revenue for Savanna Biotherapeutics is .

  • How much funding has Savanna Biotherapeutics raised over time?

    Savanna Biotherapeutics has raised $37.3M.

  • Who are Savanna Biotherapeutics’s investors?

    Civilization Ventures, Iaso Ventures, Medical Excellence Capital, and National Institutes of Neurological Disorders and Stroke have invested in Savanna Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process